Abstract:Diet-metabolite associations for foods high in monounsaturated fatty acids (MUFAs) differ between those with normo- vs. with dys- glycemia. As metabolites represent the physiological effects of food after it has been digested, processed, and absorbed, this suggests that dysglycemia alters how foods are metabolized and thus their potential health impacts. Our goal was to examine whether metabolites associated with adherence to a MSD, a diet high in MUFA, differed by glycemia status (normoglycemia vs. IFG [125<FG≥110 mg/dL]). We leveraged the longitudinal data on diet and plasma metabolites (N=2,816) in MESA-TOPMed, collected at two exams ~10y apart (baseline (BL): 2000-2002, and follow-up (FU): 2010-2011), on ~3,700 multi-ethnic US adults, ages 44-84y at baseline. Between exams, the proportion of the population with IFG increased from 25% to 40% (P<1.0*10 -16 ), providing a natural experiment to examine how MSD-metabolite associations change alongside population-level glycemia changes. We interpreted linear models which specified metabolites values as the outcome, and MSD score as the predictor, and adjusted for demographic (age, gender, race/ethnicity, income level, highest education level) and health behavior (physical activity, energy intake, smoking status, body mass index [BMI]) information, with longitudinal models also including time as a fixed effect (days since BL). Longitudinal random-intercept multi-level models identified 789 compounds associated with MSD at metabolome wide levels of significance (P<1.8*10 -5 ). Significant diet-by-time interactions (P<.05) indicated that the 241 metabolites showed associated with MSD that were time-specific, changing as population dysglycemia increased (alongside changes in other characteristics), and we observed different effect sizes for MSD-metabolite associations in those with IFG vs those with normoglycemia (t = 3.4, df = 145, P = 9.0*10 -4 ). 548 metabolites showed associations with an MSD that were time-invariant, and when analyses were stratified by glycemia status, more of these more ‘universally associated’ metabolites were significantly associated with an MSD in those with IFG and normoglycemia, vs. in just one dysglycemia group (45% vs. 15%; X 2 =117, df=2, P<2.0*10 -16 ). Our longitudinal analyses demonstrated that population-level metabolite associations with an MSD change as the population dysglycemia changes. Of course, other characteristics changed as well, and only some of these (e.g., BMI and age) were controlled for in our analyses. However, our cross-sectional analyses provided additional evidence that MSD-metabolite associations differ between those with normoglycemia vs. IFG. We are now seeking replication in other TOPMed cohorts, to support that notion that tailoring dietary advice to T2D prevention vs. management would be an important direction for future precision nutrition efforts.

Associations between dietary intake and glucose tolerance in clinical and metabolomics-based metabotypes

Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose

Differential association of dietary scores with the risk of type 2 diabetes by metabotype

Plasma metabolomic profiling of dietary patterns associated with glucose metabolism status: The Maastricht Study

Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses.

Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk: An IMI DIRECT study

A Mendelian Randomization Study of Metabolite Profiles, Fasting Glucose, and Type 2 Diabetes

Abstract P498: Different Metabolomic Associations With Mediterranean Style Diet (MSD) Scores Between Individuals With Normoglycemia vs. Impaired Fasting Glucose (IFG) in the Multi-Ethnic Study of Atherosclerosis Transomic Precision Medicine Initiative (MESA-TOPMed) Data

Abstract P108: Metabolic Profile of Diet Quality in the Multi-Ethnic Study of Atherosclerosis

Metabotypes Related to Meat and Vegetable Intake Reflect Microbial, Lipid and Amino Acid Metabolism in Healthy People

Investigating Gene-Diet Interactions Impacting the Association Between Macronutrient Intake and Glycemic Traits

A two-sample Mendelian randomization study explores metabolic profiling of different glycemic traits

Diet-gut microbiome interaction and its impact on host blood glucose homeostasis: a series of nutritional n-of-1 trials

Plasma metabolites associated with healthy Nordic dietary indexes and risk of type 2 diabetes—a nested case-control study in a Swedish population

Human Metabolome Associates with Dietary Intake Habits among African Americans in the Atherosclerosis Risk in Communities Study

Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis

Associations between Metabolomic Biomarkers of Avocado Intake and Glycemia in the Multi-Ethnic Study of Atherosclerosis

Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes

Perspective: Metabotyping—A Potential Personalized Nutrition Strategy for Precision Prevention of Cardiometabolic Disease

Characterization of metabolic responses to healthy diets and association with blood pressure: application to the Optimal Macronutrient Intake Trial for Heart Health (OmniHeart), a randomized controlled study

A Fecal Metabolite Signature of Impaired Fasting Glucose: Results From Two Independent Population-Based Cohorts